节点文献

硬通道穿刺引流术治疗老年基底节区脑出血的近期效果

Recent effect of basal ganglia hemorrhage by transcranial puncture treatment

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 伏光辉王建伟王文学康新刘宇梁袁涛

【Author】 FU Guang-hui;WANG Jian-wei;WANG Wen-xue;KANG Xin;LIU Yu-liang;YUAN Tao;Department of Neurosurgery,Eastern Hospital of Lianyungang City in Jiangsu Province;

【机构】 江苏省连云港市东方医院神经外科

【摘要】 目的探讨硬通道穿刺引流术对老年基底节区脑出血的近期临床疗效。方法选择2013年6月~2015年12月我院收治的58例老年高血压脑出血患者为研究对象,并随机分为保守组(25例)与穿刺组(33例)。给予保守组患者常规药物治疗,包括及时降低颅内压,控制血压,营养神经、对症支持治疗等,穿刺组在保守组的基础上使用LY-1型一次性颅内血肿粉碎穿刺针,两组患者均随访3个月,记录并分析两组患者病死率及存活者日常生活能力(ADL)。结果穿刺组病死率为15.2%,保守组为32.0%,差异有统计学意义(P<0.05);穿刺组3个月存活患者中ADL 1~3级占71.4%,保守组3个月ADL1~3级占35.3%,差异有统计学意义(P<0.05)。结论硬通道穿刺引流术治疗基底节区脑出血简单快捷,定位准确,创伤小,可明显降低短期死亡率,值得临床推广。

【Abstract】 Objective To explore the recent effects of basal ganglia hemorrhage by transcranial puncture treatment.Methods 58 patients with basal ganglia hemorrhage treated in our hospital from June 2013 to December 2015 were randomly divided into conservative group(n=25) and puncture group(n=33).Patients in the conservative group were given conventional medical treatment,including timely reducing intracranial pressure,controling blood pressure,nurturing nerve and symptomatic and supportive treatment etc,patients in the puncture group were treated by a YL-l type disposable intracranial hemorrhage smash puncture needle on basic of conventional medical treatment,patients in two groups were followed up for 3 months,the fatality rate and activities of daily life(ADL) in two groups were recorded and compared.Results The fatality rate in the puncture group was 15.2%,with 32.0% in the conservative group,the difference was significantly significant(P<0.05);survivors′ADL grade ADL1-3accounted for 71.4% in the puncture group,which was35.3% in the conservative group,which showed significant difference(P <0.05).Conclusion YL-1 type disposable intracranial hemorrhage smash puncture needle in treatment of basal ganglia hemorrhage is a simple,fast and accurate positioning,less traumati,low fatality rate and deserves to be promoted for clinical performance.

  • 【文献出处】 中国当代医药 ,China Modern Medicine , 编辑部邮箱 ,2016年24期
  • 【分类号】R651.12
  • 【被引频次】5
  • 【下载频次】19
节点文献中: 

本文链接的文献网络图示:

本文的引文网络